This finding is in accordance with previous studies, which proposed that changes in the expression levels of HSP90s and their co-regulators could drive tau deposition and neurotoxicity, leading to Alzheimer’s disease (AD) and other neurodegenerative diseases (tauopathies) [99]. This evidence concerns the gene MAPT and neurodegenerative disease.